Cargando…
TRAF6 promotes chemoresistance to paclitaxel of triple negative breast cancer via regulating PKM2‐mediated glycolysis
Ample evidence reveals that glycolysis is crucial to tumor progression; however, the underlying mechanism of its drug resistance is still worth being further explored. TRAF6, an E3 ubiquitin ligase, is well recognized to overexpress in various types of cancer, which predicts a poor prognosis. In our...
Autores principales: | Xu, Han, Li, Longzhi, Dong, Bing, Lu, Ji, Zhou, Kun, Yin, Xiaoxing, Sun, Huizhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587986/ https://www.ncbi.nlm.nih.gov/pubmed/37746908 http://dx.doi.org/10.1002/cam4.6552 |
Ejemplares similares
-
PKM2 and cancer: The function of PKM2 beyond glycolysis
por: DONG, GAOCHAO, et al.
Publicado: (2016) -
Exosome‐delivered circRNA promotes glycolysis to induce chemoresistance through the miR‐122‐PKM2 axis in colorectal cancer
por: Wang, Xinyi, et al.
Publicado: (2020) -
Girdin Promotes Tumorigenesis and Chemoresistance in Lung Adenocarcinoma by Interacting with PKM2
por: Cao, Fuyang, et al.
Publicado: (2022) -
ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple‐negative breast cancer models
por: Polonio‐Alcalá, Emma, et al.
Publicado: (2022) -
PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis
por: Liu, Fabao, et al.
Publicado: (2017)